<DOC>
	<DOCNO>NCT01608789</DOCNO>
	<brief_summary>This study prospective , single arm , non-randomized , multi-center clinical study conduct Europe . It design assess efficacy safety Virtue® Male Sling post-prostatectomy urinary incontinence .</brief_summary>
	<brief_title>Virtue® European Study</brief_title>
	<detailed_description />
	<mesh_term>Urinary Incontinence</mesh_term>
	<mesh_term>Enuresis</mesh_term>
	<mesh_term>Urinary Incontinence , Stress</mesh_term>
	<criteria>The subject estimate life expectancy 5 year The subject confirm stress urinary incontinence ( SUI ) medical history , urodynamics , and/or physical exam least 6 month The subject intrinsic sphincter deficiency due radical prostatectomy complete least 1 year prior implantation date The subject good bladder function The subject fail noninvasive therapy , eg . Pelvic Floor/Kegel exercise , behavioral modification , biofeedback , least 6 month The subject willing Virtue® Male Sling implant The subject able willing complete followup visit procedure indicate protocol The subject unable unwilling comply followup requirement accord study protocol The subject active urinary tract infection active skin infection region surgery ( temporary exclusion ) The subject compromise immune system condition affect heal The subject serious bleeding disorder The subject urinary incontinence mainly stress urinary incontinence The subject stress urinary incontinence due TransUrethral Resection laser surgery Prostate ( TURP ) The subject incontinence due neurogenic cause define multiple sclerosis , spinal cord/brain injury , CVA , detrusorexternal sphincter dyssynergia , Parkinson 's disease , similar condition The subject previous implant ( male sling , Artificial Urinary Sphincter ) treat stress urinary incontinence ( previous implant bulking agent allow ) The subject undergone radiation , cryosurgery , brachy therapy treat prostate pelvic cancer within 6 month The subject likely undergo radiation therapy within next 3 month The subject postvoid residual ( PVR ) &gt; = 150mL The subject recently require transurethral instrumentation urethral urethrovesical anatomosis stricture within previous 6 month The subject enrol concurrent clinical study treatment ( drug device ) could affect continence function without sponsor ' approval The subject deem unfit male sling implantation participation research protocol determine attend physician</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>Male sling</keyword>
	<keyword>Stress Urinary Incontinence</keyword>
	<keyword>Urination Disorders</keyword>
	<keyword>Urologic Diseases</keyword>
</DOC>